Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

128.90p
   
  • Change Today:
      0.90p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 25,484
  • Market Cap: 135.05m
  • RiskGrade: 90
  • Beta: 0.04
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 170.20 12.75 0.09p 1,413.9 n/a -99% 0.04p 299.8%
31-Dec-20 175.85 13.37 0.10p 1,346.5 0.2 +5% 0.04p 313.4%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2019 170 129 181 181 180 180
31-Dec-2020 176 144 n/a n/a n/a n/a
 
Earnings
31-Dec-2019 n/a 8.93p 8.86p 8.86p 8.86p 9.07p
31-Dec-2020 n/a 9.41p n/a n/a n/a n/a
 
Dividend
31-Dec-2019 n/a 4.00p 3.80p 3.80p 3.80p 3.87p
31-Dec-2020 n/a 4.17p n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 2 1 1 1 2
Buy 0 0 0 0 0 0
Neutral 0 0 1 1 1 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 2 2 2 2 2
 
Average Rec n/a 10.00 7.50 7.50 7.50 10.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Cello Health Market Data

Currency UK Pounds
Share Price 128.90p
Change Today 0.90p
% Change 0.70 %
52 Week High 139.50
52 Week Low 96.00
Volume 25,484
Shares Issued 104.77m
Market Cap 135.05m
Beta 0.04
RiskGrade 90

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.11% below the market average58.11% below the market average58.11% below the market average58.11% below the market average58.11% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
40.77% above the market average40.77% above the market average40.77% above the market average40.77% above the market average40.77% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
26.54% below the market average26.54% below the market average26.54% below the market average26.54% below the market average26.54% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Growth
31.09% below the market average31.09% below the market average31.09% below the market average31.09% below the market average31.09% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 19-Jun-2019

Time Volume / Share Price
10:11 2,270 @ 128.90p
09:43 6,433 @ 129.00p
09:43 6,433 @ 129.00p
09:43 10,000 @ 129.00p
08:33 348 @ 129.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page